Marcello Tonelli1, Paul Muntner2, Anita Lloyd3, Braden Manns4, Scott Klarenbach5, Neesh Pannu3, Matthew James4, Brenda Hemmelgarn4. 1. Department of Medicine, University of Alberta, Edmonton, Canada; Department of Public Health Sciences, University of Alberta, Edmonton, Canada. Electronic address: mtonelli-admin@med.ualberta.ca. 2. Department of Epidemiology, School of Public Health, University of Alabama, Birmingham, AL. 3. Department of Medicine, University of Alberta, Edmonton, Canada. 4. Department of Medicine, University of Calgary, Calgary, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Canada. 5. Department of Medicine, University of Alberta, Edmonton, Canada; Department of Public Health Sciences, University of Alberta, Edmonton, Canada.
Abstract
BACKGROUND: Elucidation of the relationship between age, kidney function, and absolute coronary risk would facilitate efforts to promote chronic kidney disease (CKD) as a high-risk state for future vascular events and justify current recommendations for statin treatment in CKD. STUDY DESIGN: Population-based study. SETTING & PARTICIPANTS: 1,268,538 people with data for estimated glomerular filtration rate and albuminuria who were treated in a single Canadian province. PREDICTORS: CKD risk groups (G1, G2, G3a, G3b, and G4 had estimated glomerular filtration rate ≥90, 60-89.9, 45-59.9, 30-44.9, and 15-29.9 mL/min/1.73 m2, respectively; A1, A2, and A3 had albuminuria with albumin-creatinine ratio [ACR]<30 mg/g or dipstick urinalysis negative, ACR of 30-300 mg/g or dipstick trace or 1+, and ACR >300 mg/g or dipstick ≥ 2+, respectively) and age (<40, 40-49, ≥50 years). OUTCOMES: Rates of coronary death or nonfatal myocardial infarction (expressed per 1,000 person-years), stratified by age, sex, and CKD stage. MEASUREMENTS: The first available serum creatinine value and the corresponding date were set as the index serum creatinine value and index date, respectively. ACR or dipstick urinalysis data were obtained from the periods defined by 6 months before and after the index creatinine value. RESULTS: Absolute rates of coronary death or nonfatal myocardial infarction were consistently greater than 10 per 1,000 person-years for people with CKD and 50 years or older, regardless of CKD stage. However, absolute rates of the composite outcome were consistently less than 10 per 1,000 person-years for those younger than 50 years. LIMITATIONS: Single Canadian province, median follow-up only 4.0 years. CONCLUSIONS: People with CKD who are 50 years or older should be considered at the highest risk of coronary events. In contrast, consideration of other risk factors will be required when assessing future risk among people with CKD who are younger than 50 years.
BACKGROUND: Elucidation of the relationship between age, kidney function, and absolute coronary risk would facilitate efforts to promote chronic kidney disease (CKD) as a high-risk state for future vascular events and justify current recommendations for statin treatment in CKD. STUDY DESIGN: Population-based study. SETTING & PARTICIPANTS: 1,268,538 people with data for estimated glomerular filtration rate and albuminuria who were treated in a single Canadian province. PREDICTORS: CKD risk groups (G1, G2, G3a, G3b, and G4 had estimated glomerular filtration rate ≥90, 60-89.9, 45-59.9, 30-44.9, and 15-29.9 mL/min/1.73 m2, respectively; A1, A2, and A3 had albuminuria with albumin-creatinine ratio [ACR]<30 mg/g or dipstick urinalysis negative, ACR of 30-300 mg/g or dipstick trace or 1+, and ACR >300 mg/g or dipstick ≥ 2+, respectively) and age (<40, 40-49, ≥50 years). OUTCOMES: Rates of coronary death or nonfatal myocardial infarction (expressed per 1,000 person-years), stratified by age, sex, and CKD stage. MEASUREMENTS: The first available serum creatinine value and the corresponding date were set as the index serum creatinine value and index date, respectively. ACR or dipstick urinalysis data were obtained from the periods defined by 6 months before and after the index creatinine value. RESULTS: Absolute rates of coronary death or nonfatal myocardial infarction were consistently greater than 10 per 1,000 person-years for people with CKD and 50 years or older, regardless of CKD stage. However, absolute rates of the composite outcome were consistently less than 10 per 1,000 person-years for those younger than 50 years. LIMITATIONS: Single Canadian province, median follow-up only 4.0 years. CONCLUSIONS:People with CKD who are 50 years or older should be considered at the highest risk of coronary events. In contrast, consideration of other risk factors will be required when assessing future risk among people with CKD who are younger than 50 years.
Authors: Juli Finlay; Todd Wilson; Pantea Amin Javaheri; Winnie Pearson; Carol Connolly; Meghan J Elliott; Michelle M Graham; Colleen M Norris; Stephen B Wilton; Matthew T James Journal: CMAJ Open Date: 2020-12-10
Authors: Rachel Jeong; Robert R Quinn; Pietro Ravani; Feng Ye; Manish M Sood; David Massicotte-Azarniouch; Marcello Tonelli; Brenda R Hemmelgarn; Ngan N Lam Journal: Can J Kidney Health Dis Date: 2020-10-08
Authors: Ngan N Lam; Scott Klarenbach; Robert R Quinn; Brenda Hemmelgarn; Marcello Tonelli; Feng Ye; Pietro Ravani; Aminu K Bello; Daniel C Brennan; Krista L Lentine Journal: Transplant Direct Date: 2018-09-06
Authors: Hugh Gallagher; Jennifer Dumbleton; Tom Maishman; Amy Whitehead; Michael V Moore; Ahmet Fuat; David Fitzmaurice; Robert A Henderson; Joanne Lord; Kathryn E Griffith; Paul Stevens; Maarten W Taal; Diane Stevenson; Simon D Fraser; Mark Lown; Christopher J Hawkey; Paul J Roderick Journal: Trials Date: 2022-04-21 Impact factor: 2.728